Evidence map›Paper›PMID 30841535›Full record

ReviewMicroorganisms2019

MmpL Proteins in Physiology and Pathogenesis of

Geoff Melly, Georgiana E Purdy

Abstract readReview
In one paragraph

Review in Microorganisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Verapamil and its metabolite norverapamil inhibit theProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. International journal of molecular sciences · 2025
    Review
  14. Lipid Trafficking in Diverse Bacteria.Accounts of chemical research · 2025
    Review
  15. Article
  16. Article
  17. Frontiers in microbiology · 2025
    Article
  18. Article
  19. Article
  20. Role of bacterial multidrug efflux pumps during infection.World journal of microbiology & biotechnology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Geoff MellyDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239, USA. melly@ohsu.edu.ORCID 0000-0002-5437-4716
Georgiana E PurdyDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239, USA. purdyg@ohsu.edu.

Funding

INTERACTIONS AT THE MICROBE/HOST INTERFACET32AI007472 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LANDFEAR, SCOTT M · 1995 to 2019
$6.7M
Metabolite modulation of Mtb regulators of cell wall biogenesisR01AI123148 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI PURDY, GEORGIANA E., YU, EDWARD W · 2017 to 2021
$2.4M
TB Membrane Transporters and Intrinsic ResistanceR01AI087840 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI PURDY, GEORGIANA E. · 2011 to 2015
$1.9M
Mtb regulators of essential and virulence-associated MmpLsR56AI114664 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI PURDY, GEORGIANA E., YU, EDWARD W · 2015 to 2015
$476k
The MmpL11 interactomeR21AI113074 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI PURDY, GEORGIANA E. · 2015 to 2016
$424k
NIAID NIH HHS R01 AI123148NIAID NIH HHS R21 AI113074NIAID NIH HHS R56 AI114664NIAID NIH HHS T32 AI007472NIH HHS R01 AI087840
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cell envelopelipidslipid transportMmpLMycobacterium tuberculosis

Identifiers

PMID30841535
PMCPMC6463170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.